This site is intended for Healthcare Professionals only

CMA

white-tablets-summary

Court reinstates full £50m fine after failed thyroid drug appeal

Advanz and Cinven have no grounds to appeal multi-million fine, court rules

09 May 2025 , 1 Min Article

cma-1280x720

CMA accepts £23m commitment from Vifor to settle IV iron case

Vifor Pharma has offered to make a £23m payment to the NHS to address concerns over potentially misleading claims about a competitor’s IV iron treatment.

10 Dec 2024 , 1 Min Article

hydrocortisone-summary

Drug firms to pay £106m fines after court overturns ‘unjust’ tribunal decision

Court slams appeals tribunal for its approach to hydrocortisone 'cartel' case

11 Sep 2024 , 1 Min Article

notes-and-coins-summary

‘Material errors’: Drug firms overturn £35m collusion fines on appeal

Drug companies win appeal against the CMA's findings on prochlorperazine market entry.

28 May 2024 , 3 Min Article

bank-notes-summary

Tribunal overturns £106m fines for ‘cartel behaviour’ with hydrocortisone tablets

Decision to allow companies' appeal is 'fundamentally misconceived' says CMA.

11 Mar 2024 , 4 Min Article

merger-and-acquisition-summary

Merger of LloydsDirect into P2U a step closer as CMA order lifted

CMA lifts order that barred the two companies from taking steps towards integration

13 Feb 2024 , 1 Min Article

investigation-summary

CMA investigates LloydsDirect acquisition by Pharmacy2U

The regulator has served an initial enforcement order amid competition concerns.

01 Dec 2023 , 2 Min Article

emis-1280x720

EMIS purchase by UnitedHealth provisionally cleared by CMA

The Competition and Markets Authority has provisionally cleared £1.2bn purchase of EMIS by US health care giant UnitedHealth following an “in-depth investigation”.

15 Aug 2023 , 1 Min Article

acquisition-summary

Competition watchdog poised to approve Well’s acquisition of 46 pharmacies

Multiple has found buyers for seven existing branches to address takeover concerns

27 Jul 2023 , 1 Min Article

New Project(17).jpg

Bestway purchase of Lexon raises competition concerns, says CMA

Proposals have been submitted to offload pharmacies following CMA investigation.

15 Jun 2023 , 2 Min Article

medicines summary.jpg

Watchdog: Govt should monitor hub & spoke for competition risks

There may be long-term risks to competition, says CMA

19 Jul 2022 , 1 Min Article

Nick Kaye copy.jpg

NPA to seek competition watchdog's views on hub and spoke proposals

Concerns that hub and spoke could weaken independents' buying margins and concentrate wholesaler power.

17 Mar 2022 , 1 Min Article

Disqualified 1280.jpg

CMA disqualifies former Lexon director over illegal information sharing

Watchdog disqualifies Pritesh Sonpal from taking up a director's role in Britain for four years.

12 Jan 2022 , 1 Min Article

tablet medicine drug summary.jpg

Drug companies fined £260m for hydrocortisone price fixing

Drug companies fined £260m for "excessive and unfair" price hikes to hydrocortisone tablets over a 10 year period.

15 Jul 2021 , 1 Min Article

drug-tablet-pill-medicine-CMA-collusion-summary.jpg

GSK fined £22m over paroxetine 'pay for delay' deal

The Competition Appeal Tribunal has upheld a previous finding that GSK paid generic drugs companies £50m to delay bringing paroxetine to the market.

10 May 2021 , 1 Min Article

money notes cash finance financial profit summary.jpg

Lexon's appeal against £1.2m fine for collusion dismissed

The Competition Appeal Tribunal has dismissed pharmaceutical company Lexon’s appeal against a £1.2m fine for breaking competition law. 

25 Feb 2021 , 1 Min Article

Change privacy settings